GRDN Guardian Pharmacy Services, Inc. Class A Common Stock
$36,35
Precio · May 20, 2026
Fundamentales a fecha de May 6, 2026
Rango 52S
$19–$41
77% of range
Calificación del Analista
STRONG BUY
12 analysts
Precio Objetivo
$43
+19% upside
P/E (TTM)
—
ROE
24.8%
Margen de Beneficio Neto
3.4%
GRDN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$36.35
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
—
Ingresos (TTM)
$1.45B
Rendimiento div.
—
ROE
24.8%
Deuda/Capital
—
Rango 52S
$19 – $41
GRDN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$1.45B
2023-12-31
→
2025-12-31
BPA
—
Flujo de caja libre
$87M
2024-12-31
→
2025-12-31
Márgenes
3.4%
2024-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
GRDN
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
GRDN
Mediana de Pares
Gross Margin (Margen Bruto)
20.2%
20.2%
Operating Margin (Margen Operativo)
5.0%
—
Net Profit Margin (Margen de Beneficio Neto)
3.4%
1.2%
ROA
13.4%
1.1%
ROE
24.8%
2.3%
ROIC
22.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
GRDN
Mediana de Pares
Current Ratio (Ratio corriente)
1.4
1.6
Quick Ratio (Ratio Rápido)
1.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
GRDN
Mediana de Pares
Revenue YoY (Ingresos interanuales)
17.9%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
GRDN
Mediana de Pares
GRDN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
12 analistas
- Compra fuerte 6 50,0%
- Compra 5 41,7%
- Mantener 1 8,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
6 analistas · 2026-05-16
Mediana
$43.00
← Por Debajo de Todos los Objetivos
$36.35
Mín
$42.00
Máx
$45.00
Objetivo mediano
$43.00
+18,3%
Objetivo medio
$43.17
+18,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.01%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $0.21 | $0.24 | -0.03% |
| 31 de diciembre de 2025 | $0.33 | $0.26 | 0.07% |
| 30 de septiembre de 2025 | $0.15 | $0.17 | -0.02% |
| 30 de junio de 2025 | $0.14 | $0.16 | -0.02% |
| 31 de marzo de 2025 | $0.15 | $0.18 | -0.03% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| OPCH | $5.00B | 25.1 | 13.0% | 3.7% | 15.4% | 19.3% |
| CRVL | $5.75B | 61.2 | 12.6% | 10.6% | 30.6% | 23.4% |
| LFST | $2.73B | — | 13.9% | 0.68% | 0.65% | — |
| PRVA | $2.93B | 131.7 | 22.3% | 1.1% | 3.3% | — |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1.45B | $1.23B | $1.05B | |
| Cost of Revenue | $1.16B | $984M | $838M | |
| Gross Profit | $293M | $244M | $208M | |
| SG&A Expense | $220M | $307M | $167M | |
| Operating Income | $73M | $-63M | $41M | |
| Other Non-op | $1M | $-279.0K | $-367.0K | |
| Pretax Income | $73M | $-66M | $38M | |
| Income Tax | $24M | $5M | $0 | |
| Net Income | $49M | $-110M | · | |
| EBITDA | $95M | $-43M | · |
Balance general 24
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $66M | $5M | $752.0K | |
| Receivables | $102M | $97M | $77M | |
| Inventory | $43M | $41M | $37M | |
| Other Current Assets | $11M | $10M | $15M | |
| Current Assets | $222M | $152M | $130M | |
| PP&E (Net) | $56M | $50M | $45M | |
| PP&E (Gross) | $143M | $128M | $114M | |
| Accum. Depreciation | $88M | $78M | $69M | |
| Goodwill | $80M | $69M | $56M | |
| Intangibles | $18M | $15M | $12M | |
| Other Non-current Assets | $436.0K | $383.0K | $358.0K | |
| Total Assets | $413M | $321M | $271M | |
| Accounts Payable | $116M | $102M | $86M | |
| Short-term Debt | · | · | $4M | |
| Current Liabilities | $161M | $144M | $138M | |
| Capital Leases | $30M | $23M | $23M | |
| Other Non-current Liabilities | $4M | $3M | $31M | |
| Total Liabilities | $195M | $171M | $211M | |
| Long-term Debt | $0 | $0 | $23M | |
| Total Debt | · | $0 | · | |
| Paid-in Capital | $139M | $125M | · | |
| Retained Earnings | $66M | $17M | · | |
| Stockholders' Equity | $218M | $150M | $60M | |
| Liabilities + Equity | $413M | $321M | $271M |
Flujo de Efectivo 14
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $22M | $20M | $18M | |
| Stock-based Comp | $14M | $131M | $-6M | |
| Deferred Tax | $3M | $701.0K | $0 | |
| Other Non-cash | $12M | $16M | · | |
| Operating Cash Flow | $100M | $58M | $71M | |
| CapEx | $13M | $15M | $985.0K | |
| Investing Cash Flow | $-32M | $-30M | $-13M | |
| Stock Issued | $29M | $120M | · | |
| Stock Repurchased | · | $55M | · | |
| Net Stock Activity | $29M | $65M | · | |
| Financing Cash Flow | $-7M | $-24M | $-57M | |
| Net Change in Cash | $61M | $4M | $145.0K | |
| Taxes Paid | $22M | $0 | · | |
| Free Cash Flow | $87M | $43M | · |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 20.2% | 19.9% | · | |
| Operating Margin | 5.0% | -5.1% | · | |
| Net Margin | 3.4% | -9.0% | · | |
| Pretax Margin | 5.1% | -5.4% | · | |
| EBITDA Margin | 6.6% | -3.5% | · | |
| ROA | 13.4% | -37.2% | · | |
| ROE | 24.8% | -77.5% | · | |
| ROIC | 22.2% | -44.8% | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 1.4 | 1.1 | · | |
| Quick Ratio | 1.0 | 0.7 | · | |
| Debt / Equity | · | 0.0 | · | |
| LT Debt / Equity | · | 0.0 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 4.0 | 4.2 | · | |
| Inventory Turnover | 27.6 | 25.5 | · | |
| Receivables Turnover | 14.6 | 14.1 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 17.9% | 17.4% | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $1.45B | $1.23B | · | |
| Net Income TTM | $49M | $-110M | · |
Estado de resultados 10
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $337M | $398M | $377M | $344M | $329M | $339M | $314M | $281M | |
| Cost of Revenue | $260M | $312M | $303M | $276M | $265M | $271M | $254M | $226M | |
| Gross Profit | $76M | $86M | $75M | $68M | $64M | $67M | $61M | $55M | |
| SG&A Expense | $59M | $55M | $58M | $56M | $51M | $50M | $165M | $39M | |
| Operating Income | $18M | $31M | $16M | $13M | $13M | $17M | $-105M | $16M | |
| Other Non-op | $772.0K | $500.0K | $437.0K | $179.0K | $271.0K | $-113.0K | $-2.0K | $-226.0K | |
| Pretax Income | $18M | $31M | $17M | $13M | $13M | $16M | $-106M | $15M | |
| Income Tax | $5M | $10M | $7M | $4M | $4M | $4M | $176.0K | · | |
| Net Income | $13M | $21M | $10M | $9M | $9M | $12M | $-122M | · | |
| EBITDA | $24M | · | $16M | $13M | $18M | · | $-105M | · |
Balance general 24
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $66M | $36M | $19M | $14M | $5M | $37M | $752.0K | |
| Receivables | $112M | $102M | $106M | $94M | $97M | $97M | $91M | $77M | |
| Inventory | $47M | $43M | $48M | $44M | $43M | $41M | $45M | $37M | |
| Other Current Assets | $11M | $11M | $8M | $13M | $11M | $10M | $7M | $15M | |
| Current Assets | $235M | $222M | $198M | $170M | $166M | $152M | $180M | $130M | |
| PP&E (Net) | $57M | $56M | $56M | $54M | $51M | $50M | $48M | $45M | |
| PP&E (Gross) | · | $143M | · | · | · | $128M | · | $114M | |
| Accum. Depreciation | · | $88M | · | · | · | $78M | · | $69M | |
| Goodwill | $80M | $80M | $80M | $76M | $69M | $69M | $68M | $56M | |
| Intangibles | $17M | $18M | $19M | $18M | $14M | $15M | $15M | $12M | |
| Other Non-current Assets | $1M | $436.0K | $387.0K | $386.0K | $388.0K | $383.0K | $374.0K | $358.0K | |
| Total Assets | $427M | $413M | $390M | $356M | $334M | $321M | $348M | $271M | |
| Accounts Payable | $109M | $116M | $122M | $105M | $102M | $102M | $107M | $86M | |
| Short-term Debt | · | · | · | · | · | · | $5M | $4M | |
| Current Liabilities | $161M | $161M | $162M | $144M | $145M | $144M | $158M | $138M | |
| Capital Leases | $30M | $30M | $27M | $27M | $22M | $23M | $24M | $23M | |
| Other Non-current Liabilities | $4M | $4M | $5M | $6M | $4M | $3M | $3M | $31M | |
| Total Liabilities | $195M | $195M | $195M | $177M | $171M | $171M | $214M | $211M | |
| Long-term Debt | · | $0 | · | · | · | $0 | $34M | $23M | |
| Total Debt | · | · | · | · | · | · | $34M | · | |
| Paid-in Capital | $141M | $139M | $138M | $134M | $129M | $125M | $122M | · | |
| Retained Earnings | $80M | $66M | $45M | $36M | $27M | $17M | $5M | · | |
| Stockholders' Equity | $232M | $218M | $195M | $180M | $163M | $150M | $134M | $60M | |
| Liabilities + Equity | $427M | $413M | $390M | $356M | $334M | $321M | $348M | $271M |
Flujo de Efectivo 10
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | |
| Stock-based Comp | $2M | $1M | $4M | $4M | $4M | $3M | $122M | $-23M | |
| Other Non-cash | $-15M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $6M | $35M | $28M | $20M | $18M | $22M | $-2M | $15M | |
| CapEx | · | $495.0K | $4M | · | · | $2M | $2M | $0 | |
| Investing Cash Flow | $-5M | $-5M | $-9M | $-13M | $-6M | $-7M | $-7M | $-1M | |
| Stock Issued | $30M | $0 | $0 | $29M | $0 | $0 | · | · | |
| Net Stock Activity | $30M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-758.0K | $-2M | $-2M | $-3M | $-48M | $45M | $-13M | |
| Net Change in Cash | $-726.0K | $29M | $18M | $5M | $9M | $-33M | $36M | $131.0K |
Rentabilidad 8
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 22.7% | · | 19.8% | 19.8% | 19.5% | · | 19.4% | · | |
| Operating Margin | 5.2% | · | 4.3% | 3.6% | 4.0% | · | -33.3% | · | |
| Net Margin | 4.0% | · | 2.6% | 2.6% | 2.9% | · | -38.8% | · | |
| Pretax Margin | 5.4% | · | 4.4% | 3.7% | 4.0% | · | -33.6% | · | |
| EBITDA Margin | 7.0% | · | 4.3% | 3.6% | 5.5% | · | -33.3% | · | |
| ROA | 3.5% | · | 2.7% | 5.1% | 5.7% | · | -70.1% | · | |
| ROE | 6.7% | · | 6.0% | 10.1% | 11.6% | · | -182.2% | · | |
| ROIC | 5.6% | · | 4.8% | 4.9% | 5.6% | · | -62.4% | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | · | 1.2 | 1.2 | 1.1 | · | 1.1 | · | |
| Quick Ratio | 1.1 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | · | |
| Debt / Equity | · | · | · | · | · | · | 0.3 | · | |
| LT Debt / Equity | · | · | · | · | · | · | 0.2 | · |
Eficiencia 3
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | · | 1.0 | 1.9 | 2.0 | · | 1.8 | · | |
| Inventory Turnover | 5.7 | · | 6.5 | 12.5 | 12.2 | · | 11.2 | · | |
| Receivables Turnover | 3.2 | · | 3.8 | 7.3 | 6.8 | · | 6.9 | · |
Valoración (TTM) 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.39B | · | $1.37B | $1.29B | $1.22B | · | $1.15B | · | |
| Net Income TTM | $42M | · | $-94M | $-104M | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $1.45B | $1.23B | $1.05B |
| Margen Bruto % | 20.2% | 19.9% | — |
| Margen Operativo % | 5.0% | -5.1% | — |
| Beneficio neto | $49M | $-110M | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Deuda / Patrimonio | — | 0.0 | — |
| Ratio corriente | 1.4 | 1.1 | — |
| Ratio Rápido | 1.0 | 0.7 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $87M | $43M | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.